Spero pivots to I&I with $1.1B deal for Innovent antibody, sells slice of Utebzi royalties for $105M Read more
Avere goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal Read more
Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs Read more
February 19, 2025 @ 9:00 am

This life science course provides a comprehensive understanding of the journey a new drug takes from initial development through to patient use. It covers everything from technical development and preclinical safety to clinical trials, regulatory approval, and commercialisation. Participants will gain insight into the processes involved in ensuring a drug’s safety, viability, and global accessibility, along with the manufacturing and supply chain considerations for scaling up production.
This course offers an in-depth understanding of the journey a new drug takes from development to patient use, covering key stages including:
And more!
Ideal for scientific, technical, and service function professionals seeking a deeper understanding of the drug development process, from discovery to patient delivery.